£159.90

It has never been this cheap. We have no record of a lower price.

£160 today · cheaper than every other day in the last 3 months

Springer Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 54 days · 54 data points (no recent data)

Historical
Generating forecast…
£166.84 £159.21 £160.87 £162.54 £164.20 £165.87 £167.53 23 July 2026 05 August 2026 18 August 2026 31 August 2026 14 September 2026
View at Amazon ↗

Price data last checked 37 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 54 days • 3 price levels

Days at Price
Current Price
1 day · current 20 days 33 days 0 8 17 25 33 £160 £165 £167 Days at Price

Price Analysis

Most common price: £167 (33 days, 61.1%)

Price range: £160 - £167

Price levels: 3 different prices over 54 days

Description

Fernando Cabanillas In 1993, Fisher et al. published the results of a randomized trial comparing three third-generation regimens against the classic CHOP combination. For several years, the oncology community had been convinced that the third generation regimens were clearly superior to CHOP. It came as a shock to many that there was no difference in outcome between the four arms of this clinical trial. The logical conclusion is that CHOP is as good as any of the other regimens tested in that study. Unfortunately, this excellent study has been misinterpreted by many as proving that there has not been any progress in the field of lymphoma during the last 20 years. Furthermore, it has led to a fatalistic attitude in the reasoning of many clinicians who feel that 'nothing works better than CHOP' and therefore that it is not worth testing new drugs or developing novel regimens. However, the process by which we move forward in the oncology field is seldom by dramatic breakthroughs. Frequently, what appears at first glance to be a breakthrough turns out later to be just a modest step forward. Several steps forward eventually add up to a major advance, but this advance goes unnoticed because of the slow nature of the process. In this volume, we have chosen to discuss several of these steps, which we feel are clearly making a positive impact on the field of lymphomas and which soon should make a major difference in therapeutic results.

Key Features

Used Book in Good Condition

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
28 February 1997
Listed Since
12 January 2007

Barcode

No barcode data available

Similar Products You Might Like

Lymphoma: Pathology, Diagnosis and Treatment
83% match

Lymphoma: Pathology, Diagnosis and Treatment

Cambridge University Press

£68.02 04 Aug 2026
Hodgkin's and Non-Hodgkin's Lymphoma: 131 (Cancer Treatment and Research, 131)
82% match

Hodgkin's and Non-Hodgkin's Lymphoma: 131 (Cancer Treatment and Research, 131)

Springer

£80.67 08 Aug 2026
Controversies in the Management of Lymphomas: Including Hodgkin’s disease: 16 (Cancer Treatment and Research, 16)
81% match

Controversies in the Management of Lymphomas: Including Hodgkin’s disease: 16 (Cancer Treatment and Research, 16)

Springer

£76.42 31 Aug 2026
Lymphoma: 115 (Methods in Molecular Medicine, 115)
80% match

Lymphoma: 115 (Methods in Molecular Medicine, 115)

Humana

£107.98 05 Aug 2026
Malignant Lymphomas: Biology and Treatment: An Update (ESO Monographs)
80% match

Malignant Lymphomas: Biology and Treatment: An Update (ESO Monographs)

Springer

£78.01 08 Aug 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
80% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£76.42 07 Aug 2026
Malignant Lymphomas and their Management: 16 (Recent Results in Cancer Research, 16)
80% match

Malignant Lymphomas and their Management: 16 (Recent Results in Cancer Research, 16)

Springer

£78.01 05 Aug 2026
Pediatric Lymphomas (Pediatric Oncology)
79% match

Pediatric Lymphomas (Pediatric Oncology)

Springer

£95.74 08 Aug 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
79% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.05 05 Aug 2026
Lymphoma: 115 (Methods in Molecular Medicine, 115)
79% match

Lymphoma: 115 (Methods in Molecular Medicine, 115)

Humana

£32.80 14 Sep 2026
Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia
79% match

Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia

£60.00 13 Aug 2026
Histopathologie der Non-Hodgkin-Lymphome: (nach der Kiel-Klassifikation)
78% match

Histopathologie der Non-Hodgkin-Lymphome: (nach der Kiel-Klassifikation)

Springer

£77.89 07 Aug 2026
Ocular and Adnexal Lymphoma (Essentials in Ophthalmology)
78% match

Ocular and Adnexal Lymphoma (Essentials in Ophthalmology)

Springer

£86.45 30 Aug 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
78% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£166.02 07 Aug 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
78% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 05 Aug 2026
Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide
78% match

Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide

Springer

£98.27 08 Aug 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
78% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£149.64 05 Aug 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
78% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£114.71 07 Aug 2026
78% match

Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice

Elsevier

£137.99 05 Aug 2026
Atlas of Hematologic Neoplasms
78% match

Atlas of Hematologic Neoplasms

Springer

£193.00 17 Aug 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
78% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 06 Aug 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
78% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.67 05 Aug 2026
Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)
78% match

Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)

Humana

£108.01 05 Aug 2026
An Epidemiological, Clinical and Pathological Study of Lymphomas
78% match

An Epidemiological, Clinical and Pathological Study of Lymphomas

LAP Lambert Academic Publishing

£68.00 27 Aug 2026